Please use this identifier to cite or link to this item:
https://doi.org/10.3390/vaccines10020225
DC Field | Value | |
---|---|---|
dc.title | Human Milk Antibodies after BNT162b2 Vaccination Exhibit Reduced Binding against SARS-CoV-2 Variants of Concern | |
dc.contributor.author | Low, Jia Ming | |
dc.contributor.author | Gu, Yue | |
dc.contributor.author | Ng, Melissa Shu Feng | |
dc.contributor.author | Wang, Liang Wei | |
dc.contributor.author | Amin, Zubair | |
dc.contributor.author | Zhong, Youjia | |
dc.contributor.author | MacAry, Paul A | |
dc.date.accessioned | 2023-05-18T07:53:20Z | |
dc.date.available | 2023-05-18T07:53:20Z | |
dc.date.issued | 2022-02-01 | |
dc.identifier.citation | Low, Jia Ming, Gu, Yue, Ng, Melissa Shu Feng, Wang, Liang Wei, Amin, Zubair, Zhong, Youjia, MacAry, Paul A (2022-02-01). Human Milk Antibodies after BNT162b2 Vaccination Exhibit Reduced Binding against SARS-CoV-2 Variants of Concern. VACCINES 10 (2). ScholarBank@NUS Repository. https://doi.org/10.3390/vaccines10020225 | |
dc.identifier.issn | 2076-393X | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/239494 | |
dc.description.abstract | SARS-CoV-2-specific antibody responses are engendered in human milk after BNT162b2 vaccination. However, the emergence of variants of concern (VOCs) raises concerns about the specificity of and potential cross-protection mediated by milk antibody responses, which are crucial for passive immunity transferred from breastfeeding mothers to their infants. In this study, we collected milk samples at three different time points pre-and post-vaccination, and measured milk IgA antibody binding to the receptor binding domain (RBD) of the original Wuhan-Hu-1 strain, and the four VOCs, namely Alpha, Beta, Gamma and Delta. We report a significant level of anti-RBD IgA in milk collected at 4–6 weeks after the second dose of vaccination compared to pre-vaccination. We observed around a 30% reduction in binding to most VOCs, including the major circulating Delta variant, compared to the original Wuhan-Hu-1 strain. As COVID-19 vaccines may take some time to be approved for infants, these individuals remain at risk for severe disease and rely mainly on transferred passive immunity. Our findings support the current recommendations for vaccinating lactating women with the aim of transferring mucosal immunity to breastfeeding infants. | |
dc.language.iso | en | |
dc.publisher | MDPI | |
dc.source | Elements | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Immunology | |
dc.subject | Medicine, Research & Experimental | |
dc.subject | Research & Experimental Medicine | |
dc.subject | breast milk antibodies | |
dc.subject | passive immunity | |
dc.subject | Pfizer vaccination | |
dc.subject | COVID-19 | |
dc.subject | immunoglobin A | |
dc.subject | BNT162b2 | |
dc.subject | Comirnaty | |
dc.subject | tozinameran | |
dc.type | Article | |
dc.date.updated | 2023-05-18T03:49:35Z | |
dc.contributor.department | MICROBIOLOGY AND IMMUNOLOGY | |
dc.contributor.department | PAEDIATRICS | |
dc.description.doi | 10.3390/vaccines10020225 | |
dc.description.sourcetitle | VACCINES | |
dc.description.volume | 10 | |
dc.description.issue | 2 | |
dc.description.place | Switzerland | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Human Milk Antibodies after BNT162b2 Vaccination Exhibit Reduced Binding against SARS-CoV-2 Variants of Concern. .pdf | 534.03 kB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.